New Life Medical Services

What New Life Medical Services does

New Life Medical Services is a privately held medicine manufacturing firm headquartered at 244 Crystal Grove Blvd, Lutz, Florida, operating as a multi-state tissue bank with state licenses and registrations in California, Florida, New York, and Oregon. Founded by leadership drawn from the organ and tissue banking industry — notably Chairman Vicki Mansavage, with 30 years in the field including a Senior VP role at LifeLink Foundation, and CEO Joshua Mansavage, with over a decade in biologics — the company distributes natural biologics products, including amniotic tissue-based therapies, alongside training resources, practice-operations guidance, and quality documentation for healthcare professionals. Per its own site, the company functions as an information and contact hub and explicitly does not advertise, market, or offer medical products for the diagnosis, cure, mitigation, treatment, or prevention of disease.

The revenue model is B2B professional services and biologics distribution, sold directly via phone (813-461-8100), email ([email protected]), and a website contact form segmented into Physician, Patient, Distributor, and Other audiences. Pricing is quote-based and not publicly disclosed. Go-to-market relies on sales-led direct outreach, content marketing through an educational blog, and professional social presence via LinkedIn profiles of leadership and medical advisors. The senior team includes COO Amanda Mansavage, CMO Dr. John Stavrakos (Physical Medicine and Rehabilitation, board-certified), VP Sales Scott Haefele, VP Finance Joseph Manjarrez, and medical advisors Joseph Greco (three patents in growth factor technology, three textbook chapters on biologics in hair regeneration since 2013) and Frederick McClimans (orthopedic surgeon, academic appointments).

Operationally, the company emphasizes compliance: it claims HIPAA controls across all operations and discloses FDA establishment registration and HCT/P listing (administrative registrations that do not constitute product approval under 21 CFR 1271.27(b)). Two FDA inspections under CEO Joshua Mansavage produced zero deviations, no inspectional observations, and no Form FDA-483s. From late 2024 through early 2026, the firm received an FDA Warning Letter as part of an enforcement sweep targeting unapproved exosome products, classifying its offerings as unapproved new drugs and unlicensed biological products. With 11-50 employees, no disclosed funding, no named customer accounts, no published revenue, and heavy family involvement in executive roles (Mansavage family holds CEO, COO, and Chairman positions), the firm operates as a small, mature, privately controlled tissue bank whose recent public posture has rotated toward defensive compliance messaging.

Name

New Life Medical Services

Legal name

New Life Medical Services

Website

https://newliferegen.com

Company type

Private

Founded year

2015

Operating status

Operating

Headcount range

11–50 employees

Short description

New Life Medical Services is a privately held, multi-state tissue bank that supplies natural biologics products and provides training, practice-operations guidance, and quality documentation to physicians and healthcare professionals across California, Florida, New York, and Oregon.

Ownership category

akta.pro rank

Product category

Biologics Manufacturing and Distribution

NAICS

Blood and Organ Banks (621991)

SIC

Biological Products, (No Disgnostic Substances) (2836), Wholesale-Medical, Dental & Hospital Equipment & Supplies (5047)

akta.pro primary industry

Specialty Pharma & Biologics Distribution (GDP-compliant) (HLAGAMAD)

akta.pro secondary industries

Third-Party/Outsourced Quality & Responsible Person Services (EU QP/RP, US Agent) (HLAGAKAO), Specialty Pharmacy & Biologics Distribution (CRAOAHAD)

Keywords

• Natural biologics products
• Regenerative medicine distribution
• Tissue banking services
• Amniotic tissue products
• Healthcare professional services

Headquarters

HQ city

Lutz

HQ country

United States

HQ region

North America

Offices1 record

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Personnel, Operations, Technology or R&D, Supply Chain, Marketing or Sales, Others

Revenue model

1. Natural Biologics Services: The company provides natural biologics-related services including training resources, practice-operations guidance, and quality documentation for healthcare professionals. The website explicitly states they do not advertise, market, or offer any products for diagnosis, cure, mitigation, treatment, or prevention of disease on their website.

Go-to-market motion1 record

Distribution channels1 record

Marketing channels3 records

Core offering

New Life Medical Services is a multi-state tissue bank that distributes natural biologics products—including amniotic tissue-based therapies and regenerative medicine products—to licensed healthcare professionals. The company supplements product distribution with training resources, practice-operations guidance, and quality documentation support for physicians and clinics. It operates as a compliance-first organization with FDA establishment registration, HCT/P listing, state licenses in Florida, California, New York, and Oregon, and HIPAA-compliant processes.

Product overview

New Life Medical Services operates as a compliance-first organization and multi-state tissue bank that supports healthcare professionals with training resources, practice-operations guidance, and quality documentation. The company provides natural biologics products and services, including amniotic tissue-based therapies. Notably, the website explicitly states it does not advertise, market, or offer medical products for the diagnosis, cure, mitigation, treatment, or prevention of disease; instead, it functions primarily as an information and contact hub for the organization. The product portfolio centers on natural biologics supported by educational and operational services for healthcare professionals.

Differentiator

Problem solved

Functional benefit

Products and services

• Natural Biologics Natural biologics products including amniotic tissue-based therapies, distributed by a multi-state tissue bank to licensed healthcare professionals.
• Training Resources Educational and training materials for healthcare professionals adopting natural biologics in clinical practice.
• Practice-Operations Guidance Operational guidance and support services for healthcare practices integrating natural biologics and regenerative medicine offerings.
• Quality Documentation Quality documentation systems and support for regulatory compliance, provided to healthcare professionals using natural biologics.

Segments1 record

Ideal customer profiles1 record

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Scale indicators4 records

Recent moves6 records

Expansion highlights4 records

Broad incumbents

• Bioventus: Bioventus is a publicly traded regenerative medicine company offering both device and biologic products for orthopedic and sports medicine applications. Comparable to New Life's regenerative biologics distribution but at significantly larger scale and broader product portfolio.
• Integra LifeSciences: Integra LifeSciences is a large, diversified medical device and regenerative technology company with a tissue technologies segment selling dural repair, wound care, and regenerative products. It overlaps with New Life's regenerative biologics distribution through a much broader portfolio and global footprint.
• Smith+Nephew: Smith+Nephew is a large global medical device company with advanced wound management and biologics franchises that overlap with New Life's biologics distribution. A broad incumbent rather than a direct competitor in tissue banking.

Direct peers

• Organogenesis: Organogenesis is a publicly traded regenerative medicine company selling biologics for wound care and surgical applications, overlapping with New Life's physician-facing tissue biologics portfolio. Comparable business model of distributing biological products to healthcare professionals under FDA-regulated pathways.
• MiMedx Group: MiMedx is a publicly traded developer and distributor of amniotic membrane-based biologics used in wound care, surgical recovery, and regenerative medicine — directly comparable to New Life's natural biologics and amniotic tissue product line. Both compete for physician customers in the same regenerative medicine channels.
• LifeNet Health: LifeNet Health is a non-profit tissue bank that recovers, processes, and distributes allograft and biologic products to hospitals and physicians. Comparable to New Life as a multi-state tissue bank distributing natural biologics under HCT/P regulatory frameworks, but at materially larger scale and broader geographic reach.
• AlloSource: AlloSource is a non-profit tissue bank that processes and distributes allograft products for sports medicine, orthopedics, and wound care. Directly comparable to New Life as a U.S. tissue bank serving physician customers with natural biologics products.
• VIVEX Biologics: VIVEX Biologics is a tissue processing and distribution company focused on amniotic and placental tissue products for regenerative medicine. Closely comparable to New Life's amniotic tissue biologics offering and physician customer base, operating in the same regulatory framework under 21 CFR Part 1271.

Emerging players

• Vericel: Vericel develops and commercializes cell therapies and specialty biologics for the sports medicine and severe burn care markets, selling through a specialty physician sales force. Comparable to New Life as a smaller, focused regenerative medicine company selling biologics to specialists.

Others

• Cryoport: Cryoport provides temperature-controlled logistics and cold chain solutions for the life sciences industry, including biologics and regenerative medicine products. Adjacent rather than directly competitive, but relevant to New Life's biologics distribution operations where cold chain integrity matters.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat3 records

Key risks6 records

Key highlights6 records

Customer concentration

• Xx.com/newliferegenmed
• Facebookfacebook.com/newliferegen

Compliance2 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles13 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about New Life Medical Services